Jan Davidson-Moncada

Jan Davidson-Moncada

Company: Wugen

Job title: Chief Medical Officer


A Phase 1/2 Dose-Escalation & Dose-Expansion Study of the Safety & Efficacy of Anti-CD7 Allogeneic CAR-T Cells (WU-CART-007) in Subjects with Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) / Acute Lymphoblastic Lymphoma (LBL) 2:45 pm

Introducing WU-CART-007 an allogeneic, fratricide resistant CAR-T cells for the treatment of CD7 hematological malignancies Discuss clinical development plans and trial updateRead more

day: Day 2 - Track B - Afternoon

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.